Zurück zu Projekte

16640.1 PFLS-LS

16640.1 PFLS-LS

Zusammenfassung

Identification and characterization of specific venom-derived peptides inhibiting the Tumour Necrosis Factor receptor 1: development of novel anti-inflammatory drug candidates

Weitere Texte

Abstract

Our objective is the discovery of venom peptides selectively inhibiting the binding of Tumor Necrosis Factor (TNF) to TNF receptor 1 (TNFR1) as anti-inflammatory drug candidates. Active venom extracts identified after screening of a library using a novel assay will be submitted to deconvolution. After purification, structural elucidation and synthesis of the best candidates, the most promising molecules will be characterized and their druggability potential will be assessed.

Beteiligte

Vincent Mutel

Wirtschaftspartner

vincent.mutel@inflamalps.com

INFLAMALPS SA CHE-477.522.287 Vincent Mutel Route de l'Ile-au-Bois 1A 1870 Monthey VS CH

Gerardo Turcatti

Kontaktperson

gerardo.turcatti@epfl.ch

EPFL LCC BSF Gerardo Turcatti Station 15 1015 Lausanne VD CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2014-10-31
Enddatum
2016-01-31
Bewilligte Gesamtkosten
CHF 186610.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T490 Biotechnology 100.0%